Pre-admission medication management assessment

Within 30 days prior to admission, the ALR shall consult with the prospective resident’s healthcare practitioner regarding: (1) The prospective resident’s current medication profile, including a review of nonprescription drugs; (2) Possible adverse interactions; (3) Common expected or unexpected side effects; and (4) The potential that such medications have to act as chemical restraints.